BKS Advisors’s Ligand Pharmaceuticals LGND Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-5,057	Closed	-$866K	–	214
2018 Q3	$866K	Buy	+5,057	New	+$866K	0.32%	79